Applied Materials Inc. (AMAT)

Applied Materials has fallen hard from its highs even as its business keeps growing. The stock closed at $372.63 on November 10, 2026, 49.62% below its 52-week high of $739.67, and it sits below its 20-day EMA, 50-day SMA and 200-day SMA. For investors, the question is whether strong reported results can carry a share price that the market is currently pricing against.

Applied Materials has beaten EPS estimates in all eight of its most recent reports. The August 13, 2026 report was the most recent beat, with adjusted EPS of $3.50 against an estimate of $3.39, a 3.24% beat. Yet the share price fell 5.12% in the first session after that report. Across the eight reports, six were followed by a lower share price in the first session. The record shows that a beat alone has not been enough to lift the stock, which suggests investors have been focused on expectations for the next quarter rather than the figure reported.

The company reports a net profit margin of 30.05% and an operating margin of 33.74%, and its return on equity of 41.07% is well above the sector median of 13.4%. Debt-to-equity is 0.29. These figures are the core of the company's strength, and they explain why CleaRank scores the profitability and balance sheet factor strongly positive.

At a trailing P/E of 32.15, the stock is 8.4% below the sector median P/E of 35.1, which places it broadly in line with peers on earnings. The gap between the two multiples reflects the high margins the company earns on each dollar of revenue, and it is the reason the valuation factor reads neutral rather than positive.

Insiders sold $180.7M of stock over the last 18 months across 21 sales, and made no open-market purchases in that period. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than open-market buying would be.

The base case for the coming months is that the stock keeps trading in a wide range while the moving averages stay above the price. Analysts remain strongly supportive: 35 of 41 rate the stock Buy or Strong Buy, none rate it Sell, and the median 12-month target is $610.00, 63.7% above the price. Those targets are the analysts' figures, not CleaRank's. The gap between price and targets would narrow if the price reclaims the 20-day EMA at $393.59 and then the 50-day SMA at $441.30, which would show the trend turning. The picture would weaken if the price loses the 52-week low of $203.40. Analysts expect EPS to grow 35.8% in the current fiscal year and 45.0% in the next one, so the earnings path is the main test for the outlook. The stock's beta of 1.67 means it can move more than the market in either direction.

Support sits at the 52-week low of $203.40, the only level below the price; a fall there would be the next test. Resistance comes first at the 20-day EMA of $393.59, which the price is trading below. Above it is the 50-day SMA at $441.30, then the 200-day SMA at $445.86, which sits just above it and marks a second area where the averages cluster. The 52-week high of $739.67 is the furthest level above the price.